Please ensure Javascript is enabled for purposes of website accessibility

Medtronic Recalls Insulin Pumps Over Safety Risk

By Todd Campbell - Feb 12, 2020 at 11:36AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Retainer rings on its MiniMed 630G and MiniMed 670G insulin pumps have been breaking, which can lead to a health hazard for users.

One of the largest manufacturers of medical devices is recalling two of its popular insulin pumps. Medtronic (MDT -2.53%) issued a recall through the Food and Drug Administration for its MiniMed 630G and MiniMed 670G pumps on Wednesday, advising patients to inspect their devices and contact the company for a replacement pump if their pump's retaining ring is loose, broken, or missing. The recall affects 322,005 devices manufactured and distributed prior to October 2019.

Letters on blocks spell the word recall.

IMAGE SOURCE: GETTY IMAGES.

The retaining ring is responsible for locking the insulin reservoir to the insulin pump. The company has received 26,421 complaints that retaining rings on the MiniMed 630G and MiniMed 670G can malfunction, potentially resulting in life threatening over- or under-delivery of insulin. Medtronic says it's aware of 2,175 injuries and 1 death associated with this issue.

Patients are instructed to regularly inspect the retaining ring for problems. If they notice one, they are advised to "discontinue using the insulin pump and revert to a back-up plan of manual insulin injections per your doctor's recommendations." The company also says patients should not "insert the reservoir back into your pump while connected because you could mistakenly give yourself a large insulin bolus."

Patients can request their replacement pumps by filling out a form online or calling Medtronic at (877) 585-0166.

In November, Medtronic reported strong sales of the MiniMed 670G were driving double-digit percentage growth in insulin pump sales and double-digit revenue growth in related supplies. That helped lift sales in its diabetes segment during its fiscal Q2 by 4.3% year over year to $596 million.

 

 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Medtronic plc Stock Quote
Medtronic plc
MDT
$103.57 (-2.53%) $-2.69

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
349%
 
S&P 500 Returns
122%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.